Browsing UiS Brage by Subject "pancreatic cancer"
Now showing items 1-5 of 5
-
Circulating and disseminated tumour cells as potential biomarkers for treatment response and disease progression in patients with locally advanced and/or metastatic pancreatic cancer
(Masteroppgave/UIS-TN-IMN/2013;, Master thesis, 2013-06-13)Introduction: Pancreatic cancer is the fourth most common cause of cancer related deaths in the Western countries. The poor prognosis of pancreatic cancer patients is often associated with early dissemination of the disease, ... -
Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis
(Peer reviewed; Journal article, 2020-02)Purpose: Pancreatic cancer is one of the most lethal of solid tumors and is associated with aggressive cancer biology. The purpose is to review the role of trypsin and effect on molecular and cellular processes potentially ... -
Isolation and Characterization of Exosomes from Cell Culture Medium and Human Plasma in Relation to Cancer Diagnostics
(Masteroppgave/UIS-TN-IKBM/2018;, Master thesis, 2018-06-15)The interest in exosomes and other extracellular vesicles (EVs) has been steadily increasing for the past several years, as a growing body of evidence for their potential use as non-invasive biomarkers for disease such as ... -
Molecular characterization of circulating tumor cells from pancreatic cancer patients by single-cell quantitative reverse transcription PCR
(Masteroppgave/UIS-TN-IMN/2014;, Master thesis, 2014-06-16)Pancreatic cancer is a highly lethal disease, which kills approximately 70 000 people per year in Europe alone. The median survival after the time of diagnosis is five to six months for patients with advanced cancer, making ... -
Refined TNM-staging for pancreatic adenocarcinoma – Real progress or much ado about nothing?
(Peer reviewed; Journal article, 2020-08)In order to provide optimal cancer care and prognostication, it is necessary to stage the disease. The 8th edition of the TNM-staging for exocrine pancreatic ductal adenocarcinoma (PDAC) system has refined size-based ...